ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Gold-backed ETFs needed only the first 10 months of this year to set a record for the amount of gold added to their portfolios in one year, taking in more than 1,000 tons.   © Reuters
Market Spotlight

Gold loses shine as investors get a shot of vaccine optimism

Price slides but weak dollar and renewed Asian buying support bull case for 2021

RURIKA IMAHASHI, Nikkei staff writer | Japan

TOKYO -- The vaccines now offering the world potential exits from the yearlong coronavirus pandemic are having bearish effects on the gold market.

The New York benchmark price for the haven asset on Nov. 30 was at $1,790 per ounce, down 13% from Aug. 6, when it was at a record $2,069. On Dec. 10, the price sat near $1,838.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more